Biotricity to join Russell Microcap(R) Index
REDWOOD CITY, Calif., Jun 23, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity to present at the 2022 H.C. Wainwright Global Investment Conference on Tuesday May 24th
REDWOOD CITY, Calif., May 23, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity issues shareholder update
REDWOOD CITY, Calif., May 05, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity to launch commercial sales of its disruptive cardiac monitoring device, Biotres in April 2022
REDWOOD CITY, Calif., Mar 22, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity named to Fast Company’s annual list of the World’s 50 Most Innovative Companies for 2022
REDWOOD CITY, Calif., Mar 08, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity, Inc. to attend 34th annual Roth Conference March 13th-15th
REDWOOD CITY, Calif., Mar 04, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity now taking pre-orders for its Biotres wireless wearable cardiac monitoring device
REDWOOD CITY, Calif., Feb 23, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity releases Fiscal 2022 third quarter financial results
REDWOOD CITY, Calif., Feb 14, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity to report third quarter fiscal 2022 financial results on February 14, 2022
REDWOOD CITY, Calif., Feb 08, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity receives FDA 510(k) clearance for its Biotres Cardiac Monitoring Device
REDWOOD CITY, Calif., Jan 24, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…
Biotricity expands distribution of new Bioheart device on Amazon.com
REDWOOD CITY, Calif., Dec 28, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) a modern medical technology company delivering innovative, remote biometric monitoring solutions,…
Biotricity completes $12 million non-dilutive debt financing
REDWOOD CITY, Calif., Dec 27, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) a modern medical technology company delivering innovative, remote biometric monitoring solutions,…
Biotricity, a leader in remote cardiac health monitoring solutions, issues company roadmap in 2021 shareholder letter
REDWOOD CITY, Calif., Dec 07, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) (“Biotricity” or the “Company”), a medical diagnostic and consumer healthcare technology company,…
Biotricity delivers Bioheart, a groundbreaking consumer Heart Monitor
REDWOOD CITY, Calif., Nov 10, 2021 (BUSINESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) a modern medical technology company focused on delivering innovative, remote biometric…
Biotricity releases fiscal 2022 second quarter financial results
REDWOOD CITY, Calif., Nov 04, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) a medical diagnostic and consumer healthcare technology company, today announced financial results…
Biotricity to report second quarter fiscal 2022 financial results on November 4, 2021
REDWOOD CITY, Calif., Nov 02, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) a medical diagnostic and consumer healthcare technology company, today announced that it will…
Biotricity launches Biocare Cardiac application for Samsung’s Galaxy Watch4 series
REDWOOD CITY, Calif., Oct 07, 2021 (ACCESSWIRE) -- Biotricity, Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the upcoming…
Remote medical diagnostic company, Biotricity, to ring the Nasdaq stock market opening bell on Thursday, October 7th
REDWOOD CITY, Calif., Oct 06, 2021 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) a medical diagnostic and consumer healthcare technology company, today announced it will be…